BNP Paribas Financial Markets
PRQR icon

BNP Paribas Financial Markets’s ProQR Therapeutics PRQR Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$513K Buy
275,631
+103,282
+60% +$170K ﹤0.01% 3749
2026
Q1 		$279K Buy
172,349
+15,200
+10% +$24.9K ﹤0.01% 3896
2025
Q4 		$317K Buy
157,149
+17,555
+13% +$41K ﹤0.01% 3822
2025
Q3 		$297K Buy
139,594
+18,100
+15% +$39.5K ﹤0.01% 3814
2025
Q2 		$248K Buy
121,494
+26,893
+28% +$43.7K ﹤0.01% 3692
2025
Q1 		$126K Buy
94,601
+19,900
+27% +$42.4K ﹤0.01% 3955
2024
Q4 		$198K Buy
74,701
+15,900
+27% +$50.5K ﹤0.01% 3871
2024
Q3 		$107K Buy
58,801
+7,300
+14% +$13.7K ﹤0.01% 3442
2024
Q2 		$85.5K Buy
51,501
+16,500
+47% +$32K ﹤0.01% 3328
2024
Q1 		$80.1K Buy
35,001
+19,100
+120% +$40.8K ﹤0.01% 3492
2023
Q4 		$31.5K Buy
15,901
+9,200
+137% +$14.1K ﹤0.01% 3626
2023
Q3 		$8.71K Sell
6,701
-3,226
-32% -$5.08K ﹤0.01% 3634
2023
Q2 		$16.1K Buy
9,927
+9,422
+1,866% +$18.4K ﹤0.01% 3604
2023
Q1 		$1.08K Sell
505
-1,700
-77% -$5.2K ﹤0.01% 3682
2022
Q4 		$8.16K Buy
2,205
+2,159
+4,693% +$2.83K ﹤0.01% 3630
2022
Q3 		$34 Sell
46
-2,968
-98% -$2.38K ﹤0.01% 4682
2022
Q2 		$2.34K Buy
+3,014
New +$2.25K ﹤0.01% 3864
2022
Q1 		– Sell
-2,326
Closed -$18.6K – 4330
2021
Q4 		$18.6K Buy
+2,326
New +$17.7K ﹤0.01% 3854
2021
Q1 		– Sell
-500
Closed -$2.1K – 4114
2020
Q4 		$2.1K Buy
+500
New +$2.11K ﹤0.01% 3998

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BNP Paribas Financial Markets's PRQR Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its ProQR Therapeutics (PRQR) stake by 60% in Q2 2026, buying an estimated $170K and bringing the position to 275,631 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

BNP Paribas Financial Markets first reported a position in PRQR in Q4 2020 and has held it in 19 quarters since. 65 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • BNP Paribas Financial Markets held 275,631 shares of ProQR Therapeutics worth $513K as of Q2 2026.
  • BNP Paribas Financial Markets bought 103,282 ProQR Therapeutics shares in Q2 2026, an estimated $170K.
  • ProQR Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3749 holding.
  • BNP Paribas Financial Markets first reported a position in ProQR Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.